Summary
- Current Price
- As of today, KROS price is $11.71, up +1.39% on
- Current Price All-Time High
- KROS price is currently -86.81% below its historical high of $88.80 set on
- Market Cap
- KROS current market cap is $357M, down -32.89% year-over-year
- PE Ratio
- KROS current PE ratio is 6.43
- Revenue
- KROS current annual revenue is $244.06M, up +6774.96% year-over-year
- Next Earnings
- The next earnings release for KROS is on
Profile
| Metric | Value |
|---|---|
| Full Name | Keros Therapeutics, Inc. |
| Ticker | NASDAQ: KROS |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | kerostx.com |
| Employees | 163 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $11.71 | |
| Price, 1D Change | +1.39% | |
| $357M | ||
| - | ||
| 6.43 | ||
| 0.82 | ||
| $244M | ||
| Revenue, 1Y Change | +6,774.96% | |
| $2.30 | ||
| EPS, 1Y Change | +145.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $2.30 | ||
| EPS Estimate | N/A | -$4.67 |
| EPS Est. Change | N/A | -303.33% |
| $244.06M | ||
| Revenue Estimate | N/A | $3.13M |
| Revenue Est. Change | N/A | -98.72% |
| Current Price | $11.71 | |
| Price Target | - | $20.00 |
| Price Tgt. Change | - | +70.79% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.12 | -$5.00 | -21.47% | |
| $2.35 | $2.30 | -1.99% | |
| -$4.67 | N/A | -303.33% | |
| -$5.05 | N/A | -319.86% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $32.05M | $3.55M | -88.92% | |
| $245.93M | $244.06M | -0.76% | |
| $3.13M | N/A | -98.72% | |
| $11.44M | N/A | -95.31% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $11.71 | |
| $15.71 | ||
| SMA 200 vs Price | +34.16% | |
| $13.37 | ||
| SMA 50 vs Price | +14.17% | |
| 0.82 | ||
| $0.62 | ||
| 46.11 | ||
| 70.11% | ||
| 45.38% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $244.06M | ||
| $2.30 | ||
| $242.55M | ||
| 99.38% | ||
| $70.62M | ||
| 28.94% | ||
| $87.01M | ||
| 35.65% | ||
| $72.13M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.06 | ||
| 15.45 | ||
| 15.45 | ||
| - | ||
| 7 | ||
| 5.84 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 6.43 | ||
| 1.46 | ||
| 1.18 | ||
| 1.25 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $303.13M | ||
| $287.42M | ||
| $342.87M | ||
| $315.43M | ||
| $39.74M | ||
| $20.41M | ||
| $16.88M | ||
| $2.41M | ||
| $1.97M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $157.05M | ||
| $171.93M | ||
| $1.51M | ||
| $0.00 | ||
| $1.51M | ||
| $0.00 | ||
| $4.88M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $107.51M | ||
| -$1.55M | ||
| -$378.47M | ||
| $1.55M | ||
| $105.95M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| B of A Securities | → | |
| Oppenheimer | → | |
| Wells Fargo | → | |
| Wedbush | → | |
| HC Wainwright & Co. | → | |
| B of A Securities | → | |
| Wedbush | → | |
| Scotiabank | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with KROS
FAQ
What is the ticker symbol for Keros Therapeutics, Inc.?
The ticker symbol for Keros Therapeutics, Inc. is NASDAQ:KROS
Does Keros Therapeutics, Inc. pay dividends?
No, Keros Therapeutics, Inc. does not pay dividends
What sector is Keros Therapeutics, Inc. in?
Keros Therapeutics, Inc. is in the Healthcare sector
What industry is Keros Therapeutics, Inc. in?
Keros Therapeutics, Inc. is in the Biotechnology industry
What country is Keros Therapeutics, Inc. based in?
Keros Therapeutics, Inc. is headquartered in United States
When did Keros Therapeutics, Inc. go public?
Keros Therapeutics, Inc. initial public offering (IPO) was on April 8, 2020
Is Keros Therapeutics, Inc. in the S&P 500?
No, Keros Therapeutics, Inc. is not included in the S&P 500 index
Is Keros Therapeutics, Inc. in the NASDAQ 100?
No, Keros Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Keros Therapeutics, Inc. in the Dow Jones?
No, Keros Therapeutics, Inc. is not included in the Dow Jones index
When was Keros Therapeutics, Inc. last earnings report?
Keros Therapeutics, Inc.'s most recent earnings report was on March 4, 2026
When does Keros Therapeutics, Inc. report earnings?
The next expected earnings date for Keros Therapeutics, Inc. is May 11, 2026
Data Sources & References
- KROS Official Website www.kerostx.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1664710/000166471026000018/0001664710-26-000018-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1664710/000166471026000018/0001664710-26-000018-index.htm
- KROS Profile on Yahoo Finance finance.yahoo.com/quote/KROS
- KROS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/kros